Common Stock, $0.0001 par value per share
- Symbol
- WGRX
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Historical · closed Jul 21, 2026
Current Report · Items 5.03, 8.01, 9.01 · 8-K
DataMeds AI, Inc.
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other Events
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K. Exhibit Description No.…
Press release in this filing
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. →Company context
We are currently not authorized to issue any shares of preferred stock. The holders of a majority of the issued and outstanding shares of our common stock approved, by written consent dated August 25, 2026, the Blank Check Amendment. Such stockholder approval will be deemed effective 20 calendar days after the date on which a definitive information statement related thereto is first sent or given to our stockholders. We filed a preliminary information statement with the SEC related thereto on August 31, 2026. As of the date of this prospectus, we have not filed a definitive information statement with the SEC or sent or given a definitive information statement to our stockholders. Promptly after the approval of the Blank Check Amendment by our stockholders is deemed effective, we expect to file the Blank Check Amendment with the Delaware Secretary of State and for it to be effective upon filing, and to promptly thereafter file a certificate of designation that designates 25,000 shares of preferred stock as the Series A Preferred Stock. Certain terms of the Series A Preferred Stock are summarized below:
Current securities
Historical securities (1)
Recent company filings
- Entry into a Material Definitive Agreement · Regulation FD DisclosureOct 26, 2026
- Regulation FD Disclosure · Other EventsOct 20, 2026
- Entry into a Material Definitive Agreement · Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Unregistered Sales of Equity SecuritiesOct 16, 2026
- Other EventsOct 13, 2026
- PRE 14C filingOct 9, 2026
Registered securities in this filing
WELLGISTICS HEALTH, INC. · 8-K · Filed 2026-07-21
Disclosure sections
Item 9.01Item 9.01 - Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
The
exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.
Exhibit Description
No. of Exhibit
──────────────────────────────────────────────────────────────────────────────────────────────────────────────────
3.1 Certificate of Amendment to Amended and Restated Certificate of Incorporation dated July 20, 2026
99.1 Press release dated July 21, 2026
104 Cover
Page Interactive Data File (embedded within the Inline XBRL document)
Filed exhibits (1)
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 PRESS RELEASE DATAMEDS AI, INC. 3000 BAYPORT DRIVE, SUITE 950 TAMPA, FLA. 33607 WEBSITE RUBENSTEIN PUBLIC RELATIONS CONTACT: JAMES LAMBERT 212-805-3024 JLAMBERT@RUBENSTEINPR. COM FOR IMMEDIATE RELEASE WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. Leading Health IT Company’s Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data TAMPA, Fla. - Tuesday, July 21, 2026 - Wellgistics Health, Inc., (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx ™ into patented pharmacy smart contracts platform PharmacyChain ™, today announced that it has officially completed its name change to DataMEDS AI, Inc. (“DataMEDS” or “the Company”). Simultaneous with this announcement, the Company announced that it will begin trading under the stock symbol ‘MEDS’ on the NASDAQ Capital Market stock exchange on Wednesday, July 22, 2026. DataMeds aims to deliver a vertically aligned healthcare ecosystem to patients that expands EinsteinRx ™ ’s technological capabilities into medic…
Open exhibit ↗